News
Keep up to date with our latest announcements.
April 16, 2026
Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies
March 23, 2026
Interna Therapeutics Announces Human Challenge Trial Agreement with the University of Oxford to Advance Intranasal MNM-siRNA SARS-CoV-2 Prophylaxis Program
May 15, 2025
Interna Therapeutics Announces Successful Completion of Phase I Clinical Trial of Intranasal COVID-19 Drug
December 5, 2024
Interna Therapeutics Reports on an Ongoing Phase I Clinical Trial of an Intranasal COVID-19 Drug
Interna Therapeutics will be attending the J.P. Morgan 43rd Annual Healthcare Conference on January 13-16, 2025, in San Francisco, CA, USA
Interna Therapeutics announces that it will present at the upcoming Investival Showcase conference on November 18, 2024, in London, UK
November 4, 2024